However, FGFR3 alteration was rarely observed in NSCLC, and was detected in 0.1% of adenocarcinomas and 0.6% of squamous cell carcinomas, respectively (AACR Project GENIE Consortium 2017; Qin et al. 2019). Here, FGFR3 is linked to adenocarcinoma.